In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Latest From Zynex, Inc.

Deal Watch: Merck Looks To Technology Platform Partners For Cytokine Agonist Discovery, Drug Delivery

Plus deals involving Moderna/Metagenomi, Agomab/Origo, Selecta/Ginkgo, Teva/MODAG, Boehringer Ingelheim/Thoeris and X-Chem/ComInnex/Glamorous AI.

Deal Watch Business Strategies

Dealmaking Quarterly Statistics, Q3 2021

In the third quarter of 2021, medical device company M&A values reached $7.1bn, while in vitro diagnostic firms and research tools players completed M&A activity that totaled $6.7bn.

Deals Financing

As Teva's Neurology Portfolio Gains Momentum, New Assets Join The Pipeline

Q3 results show Austedo appears headed towards blockbuster status, and the company signed a collaboration with MODAG for two compounds for neurodegenerative diseases.

Neurology Deals

Medtech Execs On The Move, August 2014

Recent executive-level company changes and promotions in the medical device and diagnostics industries.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Radiofrequency Devices
    • Rehabilitation Equipment and Devices
  • Other Names / Subsidiaries
    • Arizona Ventures, Inc.
    • Dan Med, Inc.
    • NeuroDyne Medical Corporation
    • Stroke Recovery Systems, Inc.
UsernamePublicRestriction

Register